Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > Biotek
View:
Post by MoneyMouth on Jan 14, 2021 8:47pm

Biotek

Up or down Tomorrow?
Comment by BioTeck on Jan 14, 2021 9:38pm
My guess is that we get news before the conference. Morning down a bit. Then surge leading up to news. Then depending on contents, we go up or down. My gut feel is that a lot of this news release is baked into the price so I'm going to say a bit of a selloff towards EOD. If they add some collab or license deal then depending on the details we should go up.
Comment by MoneyMouth on Jan 15, 2021 12:31am
A halt would be better from a marketing stand point
Comment by BioTeck on Jan 15, 2021 1:02am
I respectfully disagree. A halt gives people too much time to absorb and digest. Depending on the contents of the release, it's hard to say whether a halt is warranted. If they say none of the patients are taking insulin anymore, then yes, halt away. If it's reduced insulin by 10 percent average with some patients more and others less, then no halt. That is my opinion anywyays. I expect a ...more  
Comment by MedStocks2 on Jan 15, 2021 10:21am
In this case a halt actually might be necessary. If the presentation contains material news but it is restricted to conference participants until after the presentation or after the conference, a halt allows the company to respect the restriction while preventing advantageous trading until an equivalent news release is public.
Comment by Redbaron2211 on Jan 15, 2021 10:26am
Agree. I believe the presentation is open to public but they might still be required to halt or put out a NR.
Comment by BioTeck on Jan 15, 2021 10:38am
The presentation is open you just need to pay 300 dollars to register. IF they are presenting material info, there WILL be a NR released BEFORE the presentation. The stock won' t be halted IMO. If I was a gambling man, I'd say there is news released at the start or the presentation or an hour or 2 before. Nice gains!
Comment by Redbaron2211 on Jan 15, 2021 10:46am
Didn't realize the cost. Agree. Happy to see some recognition here. I believe these results will take some time to digest but if all goes well it will signal the start of bigger moves ahead. In the big picture this is just the start.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities